LFCR vs SBAC · rev $75.5M vs P/E 30, rev $1.42B
Lifecore Biomedical Inc. (LFCR) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
LFCR currently screens at market cap $207.1M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the LFCR and SBAC stock pages for the full models.
Not investment advice.